license
-
Biologics
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
– Allows for the processing of allogeneic (non-autologous) donor tissue material, including stem cells, for medical research – MELVILLE, N.Y.,…
Read More » -
Biologics
BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing
–License will enable expanded clinical operations for investigator-initiated trials and potential “right to try” uses of BRTX-100.— MELVILLE, N.Y., May 31,…
Read More » -
Biologics
BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
— Intellectual Property Provides a Cell-Based Therapeutic Platform Designed to Target All Avascular Zones— MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE)…
Read More » -
Regulatory
Taiwan Food and Drug Administration Grants CTL Amedica Corp License to Market MATISSE™ ACIF Cage System
DALLAS – SEPTEMBER 15, 2022 – /OrthoSpineNews/ – The Taiwan Food and Drug Administration (TFDA), a part of the Ministry…
Read More » -
Financial
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement
Completion of Second Technical Milestone Marks Third Achievement Under Development and License Agreement TORONTO, May 28, 2021 (GLOBE NEWSWIRE) —…
Read More » -
Regulatory
CTL Amedica Sets Sights on Asian Market: Receives TFDA License for Three Products
DALLAS (PRWEB) SEPTEMBER 10, 2020 The Taiwan Food and Drug Administration (TFDA) has granted CTL Amedica Corporation a license for three…
Read More » -
Financial
Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan
June 4, 2020 TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused…
Read More » -
Recon
Conformis Announces Settlement of Patent Dispute
BILLERICA, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement…
Read More » -
Financial
Conformis and Stryker Execute Development, License and Distribution Agreements
BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary…
Read More » -
Financial
Abyrx® Announces Expansion of Exclusive, Worldwide License Agreement with Bezwada Biomedical; Completes $10M Equity Financing.
IRVINGTON, N.Y., Dec. 6, 2016 /PRNewswire/ — Abyrx®, Inc., a privately-held specialty biosurgical products company, today announced the expansion of its exclusive, worldwide…
Read More » -
Biologics
Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology
Warren, NJ, June 30, 2016 –(PR.com)– New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics…
Read More » -
Biologics
Bone Biologics Announces Signing of Option to License Revolutionary Bone Growth Factor Nell-1 from UCLA for Use in Osteoporosis
BOSTON — Bone Biologics (OTCQB: BBLG), an orthobiologic company focused on regenerative medicine, announced today the signing of an option…
Read More » -
Financial
Marathon Patent Group Subsidiary Orthophoenix LLC Enters Into License Agreement With Titanium2Bone, Inc.
LOS ANGELES, CA–(Marketwired – May 9, 2016) – Marathon Patent Group, Inc. (NASDAQ: MARA) (“Marathon”), a patent licensing and commercialization…
Read More » -
Hospitals
Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc.
PLAINSBORO, N.J., Sept. 15, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra filed a lawsuit…
Read More » -
Spine
Institute for Applied Neuroscience signs exclusive license for minimally-invasive spine surgery implant
The Medical University of South Carolina’s (MUSC) Institute for Applied Neurosciences (IAN) has successfully licensed a new, patented, minimally-invasive spine…
Read More »